GLP-1 agonist may prove beneficial to type 1 diabetes….

The cost of treating a type 2 diabetes patient throughout their lifetime is estimated to be $85,500….

Diabetes and end stage renal disease (ESRD), when together, contribute to increased cardiovascular (CV) events, such as acute myocardial infarction and stroke….

Do metabolically healthy obese individuals have higher risks for diabetes and CVD?…

How does diet, alcohol consumption, and sodium intake affect incidence or progression of CKD in diabetic patients?…

We’ve been bringing you these special newsletters about the SGLT2 inhibitors and hopefully they are helping you see how these new medications can be part of your patient treatment plan. For this edition, we have gone to some of the patients on the only SGLT2 Inhibitor currently available, Invokana. In …

Here’s out most recent list of insurance covereage. The cash price for 1 month of Invokana is $315.72. Current actual coverage is: RXE United and other discount cards are approximately $268. PSN Commercial calls it non-formulary and charges a $100 co-pay. AARP-United Health will allow the first fill with a $95 …

We hear a lot from clinicians about new drugs but we don’t always get the patient perspective until much later. Invokana (canagliflozin) has been available for several months now, though, so we spoke with a few patients to find out what their experience has been so far: "I was on …

For the past eight years, both Steve Freed and I have been delivering CEU’s on medical errors to pharmacists and nurses, and we are frequently asked what the biggest causes of errors are. After giving this considerable thought, I believe that repetitive tasks are a major cause of medication errors. …

In Part 5 of our special Homerun Slides series on Obesity, we’ll look at how weight gain can lead to prediabetes, the genes are behind some of the conditions related to diabetes, and how impaired glucose tolerance in children could be leading to diabetes in teens….